Preview

Acta Biomedica Scientifica

Advanced search

Clinical and pharmacological monitoring of drug safety in pediatrics

https://doi.org/10.12737/21590

Abstract

The 95 cases of adverse drug reactions in children were registered in the Centre of Drug Safety Monitoring of Irkutsk Region from 2009 to 2015. In 21.4 % of cases, the coexistent affections developed. Children were allergic three times more often than adults. In 14.7 % of cases severe allergic reactions were registered. Most often allergies occurred after taking immunotropic (62.2 %), antimicrobial (16.2 %) and nonsteroidal anti-inflammatory drugs (10.8 %). 10.5 % of cases concerned inefficient drug use in children under 3 years; and 36.8 % of cases concerned children aged 3 to 18 years. The following risk factors of inefficient antibiotic therapy in children with urinary system infections were determined: the duration of the disease up to 5 years, isolation of two or more infectious agents and concomitant infections of upper and lower urinary tract. Adverse drug reaction occurred more often when more than three drugs were prescribed at the same time. Such cases were generally registered in patients with infectious diseases and epilepsy. Risk of adverse reaction increased with the off-label drug use. Introduction of monitoring methods and prediction algorithms allowing to reveal with high probability and to prevent adverse drug reactions in children improved efficiency and quality of pharmacotherapy

About the Authors

N. V. Verlan
Center of Quality Control and Drug Certification of Irkutsk Region
Russian Federation


E. O. Kochkina
Center of Quality Control and Drug Certification of Irkutsk Region
Russian Federation


A. V. Kochkin
Irkutsk State Medical Academy of Continuing Education
Russian Federation


L. V. Okhremchuk
Irkutsk State Medical Academy of Continuing Education
Russian Federation


A. V. Popadyuk
Center of Quality Control and Drug Certification of Irkutsk Region
Russian Federation


References

1. Белоусов А.А., Грацианская А.Н. Клинические исследования в клинической практике // Качественная клиническая практика. - 2008. - № 2. - С. 22-23

2. Белоусов А.А., Кукес В.Г., Лепахин В.К., Петров В.И. Клиническая фармакология. Национальное руководство. - М.: ГЭОТАР-Медиа, 2014. - 976 с

3. Верлан Н.В., Рыбалко М.В., Двойникова Н.А., Кочкина Е.О., Гуменникова Е.Н. Проблемы мониторинга безопасного использования лекарственных средств // Сибирский медицинский журнал (Иркутск). - 2013. - № 6. - С. 113-114

4. Верлан Н.В., Кочкина Е.О., Двойникова Н.А., Рыбалко М.В., Попадюк А.В. Проведение мониторинга безопасности лекарственных средств // Вестник Бурятского государственного университета. Серия: Медицина, фармация. - 2014. - Вып. 12. - С. 13-16

5. Доскин В.А., Запрудов А.М. Анализ современных проблем клинической фармакологии и фармакотерапии в педиатрии // Российский вестник перинатологии и педиатрии. - 2012 . - № 3. - С. 5-11

6. Косенко В.В., Глаголев С.В. Организация системы мониторинга безопасности зарегистрированных лекарственных препаратов в Российской Федерации // Вестник Росздравнадзора. - 2012. - № 5. - С. 25-26

7. Костылева М.Н., Белоусов Ю.Б., Грацианская А.Н., Постников С.С. Оценка безопасности лекарственной терапии в клинической практике // Фармакоэкономика. - 2014. - № 1. - С. 26-31

8. Таточенко В.К. Педиатру на каждый день. - М.: Медицина, 2007. - 272 с

9. Шабалов Н.П. Детские болезни. - М.: ГЭОТАР-Медиа, 2007. - 63 с

10. Rashed A.N., Wong I.C., Cranswick N. et al. (2012). Risk factors associated with adverse drug reactions in hospitalized children: international multicentre study. Eur. J. Clin. Pharmac., 68 (5), 801-810


Review

For citations:


Verlan N.V., Kochkina E.O., Kochkin A.V., Okhremchuk L.V., Popadyuk A.V. Clinical and pharmacological monitoring of drug safety in pediatrics. Acta Biomedica Scientifica. 2016;1(3(1)):29-32. (In Russ.) https://doi.org/10.12737/21590

Views: 611


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2541-9420 (Print)
ISSN 2587-9596 (Online)